Moneycontrol PRO
HomeAuthorGaurav sharma

Gaurav Sharma

Senior Assistant Editor

Moneycontrol

Amid rising Omicron fears, will market momentum shift to pharma yet again?

BUSINESS

Amid rising Omicron fears, will market momentum shift to pharma yet again?

It may not be a holistic surge for the sector because there might be a clear distinction between stocks that could benefit out of Omicron spread due to their drugs portfolio and others who may get hit as other treatments could be postponed

CMS Info Systems IPO opens today. Should you subscribe to the issue?

BUSINESS

CMS Info Systems IPO opens today. Should you subscribe to the issue?

Majority of the brokerages hold a positive view about the company which, on December 20, garnered Rs 330 crore from 12 anchor investors

Market Crash: 27 stocks from BSE500 hit their 52 week low on December 20

BUSINESS

Market Crash: 27 stocks from BSE500 hit their 52 week low on December 20

The advance decline ratio at 0.13 was massively tilted in favor of the bears with 238 advances and 1837 declines.

India’s chemical industry will continue on growth path, says JM Financial

BUSINESS

India’s chemical industry will continue on growth path, says JM Financial

In particular, the speciality chemicals industry holds good growth opportunities and it is still not too late to participate in the value creation process, says the brokerage house

Gold Prices Today: Glitter returns as investors turn risk-shy on policy, inflation worries; resistance at Rs 48,800

BUSINESS

Gold Prices Today: Glitter returns as investors turn risk-shy on policy, inflation worries; resistance at Rs 48,800

Expect gold and silver prices to continue to hold their support levels and any decline in the prices would be buying opportunity at lower levels

Taking Stock | Sensex plunges 889 points, Nifty below 17,000; media, realty, oil & gas take a hit

BUSINESS

Taking Stock | Sensex plunges 889 points, Nifty below 17,000; media, realty, oil & gas take a hit

Broader indices nosedived as well. The BSE midcap index was down 2.4 percent and the smallcap index closed 2.1 percent lower

Indiabulls Housing Finance share drops 8% as Morgan Stanley rates it 'underweight'

BUSINESS

Indiabulls Housing Finance share drops 8% as Morgan Stanley rates it 'underweight'

The company’s ability to increase outstanding borrowings will be the key to sustainable revenue and profit growth, Morgan Stanley says

India Ratings upgrades Can Fin Homes to ‘IND AA+’ with stable outlook

BUSINESS

India Ratings upgrades Can Fin Homes to ‘IND AA+’ with stable outlook

CFHL was able to grow its loan book by a decent 7 percent in FY21 and the growth in H1FY22 has been much stronger at 13 percent on an annual basis.

Gold Price Today: Weak dollar, US economic data support precious metal prices; resistance for gold at Rs 48,800

BUSINESS

Gold Price Today: Weak dollar, US economic data support precious metal prices; resistance for gold at Rs 48,800

The increasing emphasis on controlling inflation has also increased gold’s appeal as an inflation hedge.

Indiabulls Housing Finance: What should you do after promoter stake sale?

BUSINESS

Indiabulls Housing Finance: What should you do after promoter stake sale?

Stock has good support around 230-225 levels, while resistance comes at 275 levels. Crossing above the level can show 290-300 levels

Shriram Properties IPO: GMP at Rs 15 indicates a tepid listing on December 20

BUSINESS

Shriram Properties IPO: GMP at Rs 15 indicates a tepid listing on December 20

Investors would like to see financial performance of the company in the coming quarters and then take fresh positions.

CMS Info Systems IPO opens on December 21: 10 key things to know before subscribing to the issue

BUSINESS

CMS Info Systems IPO opens on December 21: 10 key things to know before subscribing to the issue

The company is a leading player in a consolidating market with strong fundamentals, pan-India footprint and deep penetration in growing markets.

Taking Stock | Sensex, Nifty snap four-day losing streak on gains in IT; banking, pharma drag

BUSINESS

Taking Stock | Sensex, Nifty snap four-day losing streak on gains in IT; banking, pharma drag

IT, up more than 1 percent, was the only sector to close in green as all other sectoral indices ended in the negative territory, with banking, auto, pharma and realty hit the hardest

Gold Price Today: Investors try to absorb US Fed's hawkish stance; resistance for yellow metal at resistance at Rs 48,350

BUSINESS

Gold Price Today: Investors try to absorb US Fed's hawkish stance; resistance for yellow metal at resistance at Rs 48,350

Expect gold and silver prices could show dead cat bounce after Fed Open Market Committee meeting outcome

Reliance Industries tops list of biggest wealth creators, study shows

BUSINESS

Reliance Industries tops list of biggest wealth creators, study shows

Reliance retained its position as the biggest wealth creator for the third year in a row, with a 13.6% share of the total wealth created during 2016-21, according to a study by Motilal Oswal

Supriya Lifescience IPO opens today, should you subscribe?

BUSINESS

Supriya Lifescience IPO opens today, should you subscribe?

Increasing exposure to high-margin regulated markets will support operating margins, while its backward integration plans augur well for the company

Supriya Lifescience IPO opens on December 16: 10 key things to know before subscribing to the public issue

BUSINESS

Supriya Lifescience IPO opens on December 16: 10 key things to know before subscribing to the public issue

The company posted a compound annual growth rate of 17.7 percent in revenue and 77.2 percent in profit after tax over FY 2019-21. ​

23 stocks from top 5 PMS schemes that outperformed Nifty in November, worth a look

BUSINESS

23 stocks from top 5 PMS schemes that outperformed Nifty in November, worth a look

As many as 218 PMS schemes from the broader markets generated better returns than Nifty 50 in November. Here's a quick look at some of their main stock holdings for the month

HP Adhesives IPO opens today. Should you subscribe to the issue?

BUSINESS

HP Adhesives IPO opens today. Should you subscribe to the issue?

HP Adhesives has a market share of about 17 percent for solvents. It will be the second-largest company in the segment among listed entities after Pidilite Industries which owns 65 percent

Taking Stock | Sensex, Nifty end lower; auto, telecom falter, pharma and media gain

BUSINESS

Taking Stock | Sensex, Nifty end lower; auto, telecom falter, pharma and media gain

The focus will now be on the Fed policy decision due December 15 that could induce volatility, amid rising concerns over elevated inflation and risks to economic recovery for the Omicron strain, say experts

Freshly-listed companies caught the eye of mutual funds in November

BUSINESS

Freshly-listed companies caught the eye of mutual funds in November

Mutual funds deployed Rs 4,050 crore in fresh issuances in November 2021.

HP Adhesives IPO opens December 15: 10 key things to know about the offer

BUSINESS

HP Adhesives IPO opens December 15: 10 key things to know about the offer

HP Adhesives will be the second-largest company in the solvents segment among listed entities

Data Patterns IPO opens today. Should you subscribe to the issue?

BUSINESS

Data Patterns IPO opens today. Should you subscribe to the issue?

The company has strong business capabilities but there are inherent risks too due to which the brokerages recommend investors to 'subscribe to the issue for listing gains'

Data Patterns (India) IPO opens tomorrow: 10 key things to know before subscribing to the public issue

BUSINESS

Data Patterns (India) IPO opens tomorrow: 10 key things to know before subscribing to the public issue

Any cost overruns in defence projects, delays in delivery or failures to meet contract specifications may result in liquidated damages and have an adverse effect on its business, financial condition and results of operations.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347